These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


252 related items for PubMed ID: 6817339

  • 1. Blood substitutes as therapy in massive surgery and trauma.
    Tye RW.
    Prog Clin Biol Res; 1982; 108():79-89. PubMed ID: 6817339
    [No Abstract] [Full Text] [Related]

  • 2. Current perspectives on blood substitutes.
    Gould SA, Moss G.
    Curr Surg; 1987; 44(4):279-81. PubMed ID: 3665573
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Red cell substitutes: hemoglobin solution or fluorocarbon?
    Gould SA, Rosen AL, Sehgal LR, Sehgal HL, Rice CL, Moss GS.
    J Trauma; 1982 Sep; 22(9):736-40. PubMed ID: 7120525
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services?
    Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434
    [No Abstract] [Full Text] [Related]

  • 9. [The place for using erythrocyte substitutes in hemodilution: fluosol-DA and polymerized pyridoxylated hemoglobin].
    Vigneron C, Labrude P, Dellacherie E.
    Ann Fr Anesth Reanim; 1986 Feb; 5(3):260-8. PubMed ID: 3535579
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treating severe anemia in a trauma patient who is a Jehovah's witness.
    Gilcreast DM, Avella P, Camarillo E, Mullane G.
    Crit Care Nurse; 2001 Apr; 21(2):69-72, 75-8, 80-2. PubMed ID: 11858442
    [No Abstract] [Full Text] [Related]

  • 13. [The use of perftoran in clinical medicine].
    Moroz VV, Kruylov NL, Ivanitskii GR, Kaidash AN, Onishchenko NA, Simanov VA, Vorob'ev SI.
    Anesteziol Reanimatol; 1995 Apr; (6):12-7. PubMed ID: 8713413
    [No Abstract] [Full Text] [Related]

  • 14. Oxygen carriers ("blood substitutes").
    Topfer LA, Hailey D.
    Issues Emerg Health Technol; 2001 Jul; (21):1-6. PubMed ID: 11776287
    [Abstract] [Full Text] [Related]

  • 15. [Will Japanese white blood be coursing through our veins? A revolution: the first synthetic blood will soon be commercialized].
    Lecuyer G.
    Servir; 1989 Jul; 37(5):270-3. PubMed ID: 2516646
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Blood substitutes: where do we stand with the fluorocarbon approach?
    Riess JG.
    Curr Surg; 1988 Jul; 45(5):365-70. PubMed ID: 3073041
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of Fluosol-DA on the reticuloendothelial system function in surgical patients.
    Fujita T, Suzuki C, Ogawa R.
    Prog Clin Biol Res; 1983 Jul; 122():265-72. PubMed ID: 6878369
    [No Abstract] [Full Text] [Related]

  • 20. Red cell substitutes: present status.
    Sehgal LR, Sehgal HL, Gould SA, Rosen AL, DeWoskin R, Moss GS.
    Indian J Pediatr; 1987 Jul; 54(3):403-8. PubMed ID: 3301660
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.